Squarepoint’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Buy
5,201
+1,745
+50% +$734K ﹤0.01% 2194
2026
Q1
$1.31M Sell
3,456
-31,797
-90% -$13.6M ﹤0.01% 2546
2025
Q4
$15.1M Buy
35,253
+20,380
+137% +$8.87M 0.02% 875
2025
Q3
$6.66M Sell
14,873
-15,907
-52% -$7.2M 0.01% 1294
2025
Q2
$15M Buy
30,780
+12,491
+68% +$7.12M 0.02% 897
2025
Q1
$11.3M Sell
18,289
-18,223
-50% -$10.4M 0.01% 967
2024
Q4
$19.3M Sell
36,512
-5,506
-13% -$3.1M 0.02% 782
2024
Q3
$25.3M Buy
42,018
+21,846
+108% +$12.4M 0.04% 493
2024
Q2
$10.9M Buy
20,172
+8,819
+78% +$5.05M 0.02% 886
2024
Q1
$7.29M Buy
11,353
+2,499
+28% +$1.52M 0.01% 1194
2023
Q4
$5.18M Sell
8,854
-5,310
-37% -$2.97M 0.01% 1376
2023
Q3
$7.36M Buy
14,164
+4,279
+43% +$2.22M 0.02% 945
2023
Q2
$5.35M Buy
9,885
+7,802
+375% +$4.27M 0.02% 1045
2023
Q1
$1.12M Sell
2,083
-3,747
-64% -$1.91M ﹤0.01% 1810
2022
Q4
$2.98M Buy
5,830
+1,684
+41% +$820K 0.01% 1128
2022
Q3
$1.81M Buy
4,146
+1,239
+43% +$596K 0.01% 1386
2022
Q2
$1.36M Buy
+2,907
New +$1.42M 0.01% 1405
2021
Q3
Sell
-868
Closed -$412K 2962
2021
Q2
$412K Buy
+868
New +$417K ﹤0.01% 2279
2021
Q1
Sell
-1,200
Closed -$639K 3165
2020
Q4
$639K Sell
1,200
-18,103
-94% -$8.89M ﹤0.01% 1622
2020
Q3
$9.27M Buy
19,303
+6,418
+50% +$3.15M 0.12% 194
2020
Q2
$5.81M Buy
+12,885
New +$5.75M 0.09% 295
2020
Q1
Sell
-4,622
Closed -$2.03M 1937
2019
Q4
$2.03M Sell
4,622
-28,924
-86% -$12.2M 0.01% 901
2019
Q3
$14M Buy
+33,546
New +$13.7M 0.13% 205
2019
Q2
Sell
-13,206
Closed -$4.23M 2397
2019
Q1
$4.23M Sell
13,206
-2,239
-14% -$688K 0.04% 504
2018
Q4
$4.38M Sell
15,445
-17,121
-53% -$5.17M 0.05% 443
2018
Q3
$10.4M Sell
32,566
-14,788
-31% -$4.71M 0.12% 219
2018
Q2
$15.2M Buy
+47,354
New +$14.8M 0.2% 135
2018
Q1
Sell
-1,430
Closed -$348K 1729
2017
Q4
$348K Buy
+1,430
New +$325K 0.01% 1413
2017
Q3
Sell
-3,441
Closed -$704K 1636
2017
Q2
$704K Buy
+3,441
New +$685K 0.01% 834

Other funds holding CHE

Squarepoint's CHE Position: Q2 2026 in Review

Squarepoint increased its Chemed (CHE) stake by 50% in Q2 2026, buying an estimated $734K and bringing the position to 5,201 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2194.

Squarepoint first reported a position in CHE in Q2 2017 and has held it in 29 quarters since. The position peaked at $25.3M in Q3 2024. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Squarepoint held 5,201 shares of Chemed worth $2.42M as of Q2 2026.
  • Squarepoint bought 1,745 Chemed shares in Q2 2026, an estimated $734K.
  • Chemed made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2194 holding.
  • Squarepoint first reported a position in Chemed in Q2 2017 and has held it in 29 quarters since.
  • Squarepoint's Chemed position peaked at $25.3M in Q3 2024.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.